Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-surgical treatment of idiopathic granulomatous mastitis
IRCT20100706004329N10Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of prednisolone, colchicine and naproxen in Granulomatous lobular mastitis (GLM) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Ulcer, Fistula and 1 more. Started May 2021; status: completed.
02
Drugs
prednisolonecolchicinenaproxen
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on IRCT20100706004329N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100706004329N10.